Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Caenorhabditis elegans protein, CeMyoD, is related to the vertebrate myogenic regulatory factors MyoD, myogenin, MRF-4 and
Myf-5
. Like its vertebrate counterparts, CeMyoD accumulates in the nucleus of striated muscle cells prior to the onset of terminal differentiation. CeMyoD also shares functional similarities with the vertebrate myogenic regulatory factors. Viral LTR driven expression of CeMyoD in mouse 10T1/2 cells can convert this cell line into myoblasts as well as efficiently trans-activate mouse muscle-specific promoters. Furthermore, mouse MyoD expression can activate a CeMyoD-
beta-galactosidase
reporter construct in a 10T1/2 co-transfection assay.
...
PMID:Functional conservation of nematode and vertebrate myogenic regulatory factors. 133 34
In developing mouse embryos, MyoD family regulatory genes are expressed specifically in muscle precursors and mature myofibers. This pattern, taken together with the well-established ability of MyoD family members to convert a variety of cell types to skeletal muscle, suggests a significant role for these genes in regulating skeletal myogenesis. The possibility that expression of these genes may be causally associated with segregation of the myogenic lineage from other mesodermal derivatives, or with the subsequent maintenance of muscle phenotypes at later times, raises the issue of how MyoD family genes are themselves regulated during development. In this work, we have initiated studies to identify DNA sequences that govern
Myf-5
and MRF4 (herculin, myf-6) transcription.
Myf-5
is the first of the MyoD family to be expressed in the developing mouse embryo, while MRF4 is the most abundantly expressed myogenic factor in postnatal animals. In spite of their strikingly divergent patterns of expression,
Myf-5
and MRF4 are tightly linked in the mouse genome; their translational start codons are only 8.5 kilobases apart. Here, the 5' flanking regions of the mouse
Myf-5
and MRF4 genes were separately linked to a bacterial
beta-galactosidase
(lacZ) gene, and these constructs were each used to produce several lines of transgenic mice. Transgene expression was monitored by X-gal staining of whole embryos and by in situ hybridization of embryo sections. For the
Myf-5
/lacZ lines, the most intense transgene expression was in the visceral arches and their craniofacial muscle derivatives, beginning at day 8.75 post coitum (p.c.). This correlates with endogenous
Myf-5
expression in visceral arches.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice. 837 40
Newly formed somites or unsegmented paraxial mesoderm (UPM) have been cultured either in isolation or with adjacent structures to investigate the influence of these tissues on myogenic differentiation in mammals. The extent of differentiation was easily and accurately quantified by counting the number of
beta-galactosidase
-positive cells, since mesodermal tissues had been isolated from transgenic mice that carry the n-lacZ gene under the transcriptional control of a myosin light chain promoter, restricting expression to striated muscle. The results obtained showed that axial structures are necessary to promote differentiation of paraxial mesoderm, in agreement with previous observations. However, it also appeared that the influence of axial structures could be replaced by dorsolateral tissues, adjacent to the paraxial mesoderm. To elucidate which of these tissues exerts this positive effect, we cultured the paraxial mesoderm with a variety of adjacent structures, either adherent to the mesoderm or recombined in vitro. The results of these experiments indicated that the dorsal ectoderm exerts a positive influence on myogenesis but only if left in physical proximity to it. In contrast, lateral mesoderm delays the positive effect of the ectoderm (and has no effect on its own) suggesting that this tissue produces an inhibitory signal. To investigate whether axial structures and dorsal ectoderm induce myogenesis through common or separate pathways, we dissected the medial half of the unsegmented paraxial mesoderm and cultured it with the adjacent neural tube. We also cultured the lateral half of the unsegmented paraxial mesoderm with adjacent ectoderm. The induction of the myogenic regulatory factors
myf-5
and MyoD was monitored by double staining of cultured cells with antibodies against MyoD and
beta-galactosidase
since the tissues were isolated from mouse embryos that carry n-lacZ targeted to the
myf-5
gene, so that
myf-5
expressing cells could be easily identified by either histochemical or immunocytochemical staining for
beta-galactosidase
. After 1 day in culture myogenic cells from the medial half expressed
myf-5
but not MyoD, while myogenic cells from the lateral half expressed MyoD but not
myf-5
. By the next day in vitro, however, most myogenic cells expressed both gene products. These data suggest that the neural tube activates myogenesis in the medial half of paraxial mesoderm through a
myf-5
-dependent pathway, while the dorsal ectoderm activates myogenesis through a MyoD-dependent pathway. The possible developmental significance of these observations is discussed and a model of myogenic determination in mammals is proposed.
...
PMID:Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. 862 94
We have introduced the nlacZ reporter gene into the locus of the myogenic factor gene
myf-5
by homologous recombination in embryonic stem (ES) cells. Targeted ES clones were injected into precompaction morula, and the
beta-galactosidase
expression pattern was monitored. These mice permit the sensitive visualization of
myf-5
expression throughout the embryo, and provide a standard for comparing it with that seen with different
myf-5
/nlacZ transgenes. Thus, in a comparison using ES cells in chimaeric embryos containing the targeted or randomly integrated
myf-5
/nlacZ construct, we demonstrate that 5.5 kbp of
myf-5
upstream flanking sequence including exon1 and most of intron1 directs some skeletal muscle expression, but this is neither qualitatively nor quantitatively equivalent to that of the endogenous gene.
Myf-5
is expressed early, before terminal myogenesis takes place in the medial half of the somite, and subsequently it is a major myogenic factor as skeletal muscle forms. All skeletal muscle shows
beta-galactosidase
activity, even after birth, indicating that
myf-5
expression is not confined to primary myotubes, which are derived from embryonic myoblasts, but is also present in muscles containing different adult fibre types. The presence of
myf-5
transcripts from the endogenous gene in older muscle was confirmed by in situ hybridization. These results suggest that the
myf-5
gene is not activated in only a subset of muscle cells and are consistent with the results on the MyoD knockout mice.
...
PMID:Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. 889 84
Skeletal muscles in the vertebrate body are derived from the somites, epithelial spheres of cells which segment from the paraxial mesoderm in a rostral-caudal developmental gradient on either side of the neural tube. Initially, cells in the somite are multipotent and their fate depends on the environmental influences exerted by neighbouring tissues, notably the axial structures (neural tube and notochord), and the dorsal ectoderm. The ventralizing influence exerted by the notochord and floor plate of the neural tube through the action of sonic hedgehog, results in the differentiation of sclerotome which will give rise to cartilage and bone of the vertebral column and ribs. The dorsal derivatives of the somite, formed from cells in the dermomyotome, are derm and skeletal muscle. The onset of skeletal myogenesis is characterized by expression of myogenic factors, notably
myf-5
and MyoD, members of the superfamily of helix-loop-helix transcription factors. Another member of the myogenic factor family, myogenin, is subsequently expressed and leads to muscle cell differentiation with activation of the downstream muscle-specific genes. Dorsalization of the somite and subsequent myogenesis depends on the presence of axial structures and dorsal ectoderm. The Wnt family of signalling molecules are potentially implicated in this process. Muscle progenitor cells present in the medial part of the dermomyotome activate
myf-5
first and explant experiments have shown that the axial structures lead to the activation of this myogenic factor and subsequent myogenesis which results in the formation of the dorsal myotome in the central region of the somite. This contributes to the formation of axial muscles. Muscle progenitor cells in the lateral part of the dermomyotome preferentially activate MyoD and this depends on the presence of dorsal ectoderm. These cells will form the ventral aspect of the myotome, and later contribute to body wall muscles, for example. Part of the lateral progenitor population migrates away from the somite to form peripheral body muscles and the muscles of the limb. In this case myogenic factors are not initially expressed and these migratory cells are characterized by the expression of the paired-box gene Pax3. In explant experiments lateral mesoderm retards the induction of MyoD expression by dorsal ectoderm; in vivo this may be important to permit cell migration prior to differentiation. In mice carrying mutations in both MyoD and
myf-5
no skeletal muscle forms, whereas myogenesis can take place in the absence of either MyoD or
myf-5
. Normally, cells in which one gene is activated first, subsequently co-express the other, so that there rapidly cease to be distinct MyoD+ or myf-5+ populations in the embryo. In
myf-5
-/- mice no myotome forms initially, but MyoD is subsequently activated. This takes place medially, as well as laterally, under the influence of the more mature neural tube and notochord. By targetting the
myf-5
gene with an nlacZ reporter gene it has been possible to follow the fate of the early muscle progenitor cell population in which the
myf-5
gene has been activated but no
myf-5
protein is present. These
beta-galactosidase
positive cells delaminate from the dermomyotome, but instead of migrating under this epithelium to form the myotome, they migrate aberrantly. Some cells localize dorsally under the epiderm and begin to express the dermal marker, Dermo-1. Other muscle progenitor cells migrate ventrally into the sclerotomal compartment where they express an early sclerotomal marker, scleraxis. Later in the mutant mice, when cells from this compartment have condensed to form the cartilage of the ribs,
beta-galactosidase
positive cells are detectable within the ribs. These observations indicate that the early myogenic factor
myf-5
is necessary to ensure the correct positioning of myogenic progenitor cells within the embryo. (ABSTRACT TRUNCATED)
...
PMID:[Early stages of myogenesis as seen through the action of the myf-5 gene]. 918 Nov 27
Gene targeting has indicated that the bHLH transcription factors
Myf-5
and MyoD are required for myogenic determination because skeletal myoblasts and myofibers are entirely ablated in mouse embryos lacking both
Myf-5
and MyoD. Entrance into the skeletal myogenic program during development occurs following the independent transcriptional induction of either
Myf-5
or MyoD. To identify sequences required for the de novo induction of MyoD transcription during development, we investigated the expression patterns of MyoD-lacZ transgenes in embryos deficient in both
Myf-5
and MyoD. We observed that a 258-bp fragment containing the core of the -20-kb MyoD enhancer activated expression in newly formed somites and limb buds in compound mutant embryos lacking both
Myf-5
and MyoD. Importantly,
Myf-5
- and MyoD-deficient presumptive muscle precursor cells expressing
beta-galactosidase
were observed to assume nonmuscle fates primarily as precartilage primordia in the trunk and the limbs, suggesting that these cells were multipotential. Therefore, cells are recruited into the MyoD-dependent myogenic lineage through activation of the -20-kb MyoD enhancer and this occurs independently in somites and limb buds.
...
PMID:Myogenic determination occurs independently in somites and limb buds. 998 34